ATE417104T1 - G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen - Google Patents

G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen

Info

Publication number
ATE417104T1
ATE417104T1 AT00967335T AT00967335T ATE417104T1 AT E417104 T1 ATE417104 T1 AT E417104T1 AT 00967335 T AT00967335 T AT 00967335T AT 00967335 T AT00967335 T AT 00967335T AT E417104 T1 ATE417104 T1 AT E417104T1
Authority
AT
Austria
Prior art keywords
prostate cancer
protein
phor
coupled receptor
highly expressed
Prior art date
Application number
AT00967335T
Other languages
English (en)
Inventor
Arthur Raitano
Daniel Afar
Aya Jakobovits
Mary Faris
Rene Hubert
Steve Mitchell
Douglas Saffran
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of ATE417104T1 publication Critical patent/ATE417104T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00967335T 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen ATE417104T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15790299P 1999-10-05 1999-10-05

Publications (1)

Publication Number Publication Date
ATE417104T1 true ATE417104T1 (de) 2008-12-15

Family

ID=22565799

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08165936T ATE524549T1 (de) 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen
AT00967335T ATE417104T1 (de) 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT08165936T ATE524549T1 (de) 1999-10-05 2000-10-05 G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen

Country Status (13)

Country Link
EP (2) EP1220913B1 (de)
JP (2) JP4272376B2 (de)
AT (2) ATE524549T1 (de)
AU (2) AU779685B2 (de)
CA (1) CA2385032C (de)
CY (2) CY1110059T1 (de)
DE (1) DE60041073D1 (de)
DK (2) DK1220913T3 (de)
ES (2) ES2371212T3 (de)
HK (1) HK1048494B (de)
IL (1) IL147952A0 (de)
PT (2) PT1220913E (de)
WO (1) WO2001025434A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
WO2002092842A2 (en) * 2001-05-15 2002-11-21 Agensys, Inc. Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
DK1864131T3 (da) * 2005-03-03 2011-10-31 Chemcom Sa Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
JPWO2007119515A1 (ja) * 2006-03-28 2009-08-27 昇志 佐藤 新規腫瘍抗原ペプチド
JP2012196211A (ja) * 2012-04-10 2012-10-18 Japan Science & Technology Agency 前立腺癌マーカポリペプチド、該ポリペプチドに対する抗体、及び該ポリペプチドを利用した前立腺癌の診断方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
EP0206448B1 (de) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US4975287A (en) 1989-09-01 1990-12-04 Wm. Wrigley Jr. Company Gum composition containing protein macrocolloids
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
AU8221191A (en) 1990-06-27 1992-01-23 Princeton University Probes for detecting mutant p53
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
EP0773952B1 (de) 1994-07-20 2003-11-12 The General Hospital Corporation Interaktions-fullensysteme zum nachweis von protein-interaktionen
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
ATE352638T1 (de) 1995-04-11 2007-02-15 Gen Hospital Corp REVERSE ßTWO-HYBRIDß-SYSTEME
EP0832122A4 (de) 1995-06-05 1999-08-25 Human Genome Sciences Inc Humaner g-proteinrezeptor hpraj70
ES2183166T3 (es) 1996-04-26 2003-03-16 Massachusetts Inst Technology Ensayo de cribado por triple hibrido.
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
WO1998016628A1 (en) 1996-10-15 1998-04-23 The Regents Of The University Of California Animal models of human prostate cancer progression
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
EP2305027B1 (de) 1996-12-03 2014-07-02 Amgen Fremont Inc. Transgene Saügertiere, die menschlichen Ig-loci einschließlich mehrere VH und Vkappa Regionen enthalten, und davon erhaltene Antikörper
AU8555198A (en) * 1997-08-01 1999-02-22 Genset 5' ests for secreted proteins expressed in prostate
KR20010083111A (ko) * 1998-07-14 2001-08-31 길리스 스티브 전립선암의 치료 및 진단을 위한 조성물 및 방법
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
JP2003521870A (ja) * 1998-10-06 2003-07-22 インサイト・ファーマスーティカルズ・インコーポレイテッド Ｇタンパク質共役受容体タンパク質

Also Published As

Publication number Publication date
ES2316387T3 (es) 2009-04-16
HK1048494A1 (en) 2003-04-04
PT1220913E (pt) 2009-02-16
AU2005201916A2 (en) 2005-08-25
DE60041073D1 (de) 2009-01-22
CA2385032A1 (en) 2001-04-12
AU779685B2 (en) 2005-02-03
CY1112202T1 (el) 2015-12-09
CA2385032C (en) 2013-12-10
HK1048494B (en) 2009-06-12
DK1220913T3 (da) 2009-03-16
PT2003202E (pt) 2012-01-02
IL147952A0 (en) 2002-08-14
EP1220913B1 (de) 2008-12-10
EP2003202B1 (de) 2011-09-14
AU7755300A (en) 2001-05-10
EP1220913A1 (de) 2002-07-10
JP4272376B2 (ja) 2009-06-03
AU2005201916A1 (en) 2005-06-02
WO2001025434A1 (en) 2001-04-12
ATE524549T1 (de) 2011-09-15
JP4875671B2 (ja) 2012-02-15
EP2003202A2 (de) 2008-12-17
AU2005201916B2 (en) 2008-06-19
JP2009050256A (ja) 2009-03-12
EP2003202A3 (de) 2009-10-21
DK2003202T3 (da) 2012-01-16
JP2003511029A (ja) 2003-03-25
ES2371212T3 (es) 2011-12-28
CY1110059T1 (el) 2015-01-14

Similar Documents

Publication Publication Date Title
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
EP1488007A4 (de) Verlaufsdarstellung der genexpression in bioptischen tumorgeweben
MXPA02011142A (es) Plataforma de nanodispositivo multifuncional.
ATE364618T1 (de) Antikörper gegen das muc18-antigen
NO20015546D0 (no) Behandling av refrakt¶re humane tumorer med epidermale vekstfaktorreseptorantagonister
EP2444410A3 (de) Brachyurie-Polypeptide und Verwendungsverfahren
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
ATE417104T1 (de) G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen
WO2000012702A3 (en) Human genes differentially expressed in colorectal cancer
AU2003255820A1 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
HUP0300054A1 (hu) Daganatspecifikus állati fehérjék
Trieb et al. Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells
ATE373711T1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
WO2002090991A3 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
McGinnis et al. Consequences of mutations in androgen receptor genes: molecular biology and behavior
WO2001090157A3 (en) 98p7c3: homeodomain protein highly expressed in various cancers
WO2002077234A3 (en) Compositions and methods relating to colon specific genes and proteins
WO2003025135A3 (en) Genes associated with malignant neoplasms
CN100516087C (zh) 重组靶向融合蛋白GnRH-TNFαm及其抗肿瘤用途
WO2002048370A3 (en) Compositions and methods relating to colon specific genes and proteins
AU2003247704A1 (en) Methods and compositions for diagnosing hepatocellular carcinoma
WO2002042460A3 (en) Compositions and methods relating to colon specific genes and proteins
EP1243653A3 (de) E25a Protein, Methoden zur Herstellung und Verwendung
GB0119791D0 (en) Proteins,genes and their use for diagnosis and treatment of breat cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220913

Country of ref document: EP